{
  "id": "5ca61176ecadf2e73f00004e",
  "type": "yesno",
  "question": "Can TAD disruption lead to disease?",
  "ideal_answer": "TAD boundaries are insulators of genomic neighborhoods. \u03a4he disruption of these structures by genomic rearrangements can result in gene misexpression and disease.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/30241613",
    "http://www.ncbi.nlm.nih.gov/pubmed/30374058",
    "http://www.ncbi.nlm.nih.gov/pubmed/30086749",
    "http://www.ncbi.nlm.nih.gov/pubmed/29990539",
    "http://www.ncbi.nlm.nih.gov/pubmed/27111891",
    "http://www.ncbi.nlm.nih.gov/pubmed/28408976",
    "http://www.ncbi.nlm.nih.gov/pubmed/26862051",
    "http://www.ncbi.nlm.nih.gov/pubmed/22495304",
    "http://www.ncbi.nlm.nih.gov/pubmed/25959774"
  ],
  "snippets": [
    {
      "text": "its perturbation will lead to human disease, highlighting the accumulating evidence that links the diverse 3D genome architecture components to a multitude of human diseases and the emerging mechanisms by which 3D genome derangement causes disease phenotypes.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29990539",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "TAD boundaries are insulators of genomic neighborhoods. In this issue, Sun et\u00a0al. show that disease-associated tandem repeats are located to TAD boundaries and affect their insulation. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30241613",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Recent studies of TAD boundaries disrupted in engineered mouse models show that boundary mutations can recapitulate human developmental disorders as a result of aberrant promoter-enhancer interactions in the affected TADs",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28408976",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Similar boundary disruptions in certain cancers can result in oncogene overexpression, and CTCF binding sites at boundaries appear to be hyper-mutated across cancers.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28408976",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "the disruption of these structures by genomic rearrangements can result in gene misexpression and disease.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26862051",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "TAD disruption as oncogenic driver.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27111891",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Recent studies have shown that TAD disruption is often found in cancer cells and contributes to oncogenesis through two mechanisms.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27111891",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Disruption of TAD boundaries results in aberrant gene expression by exposing genes to inappropriate regulatory elements.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27111891",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "However, it is not clear to which extent TAD regions are conserved in evolution and whether disruption of TADs by evolutionary rearrangements can alter gene expression.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30086749",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Disruption of this organization by structural variations can lead to ectopic interactions between enhancers and promoters, and to alteration of genes expression patterns.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30374058",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Disruption of TADs can result in altered gene expression and is associated to genetic diseases and cancers.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30086749",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Deletion in 2q35 excluding the IHH gene leads to fetal severe limb anomalies and suggests a disruption of chromatin architecture.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30374058",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "We demonstrate that disruption of TADs can rewire long-range regulatory architecture and result in pathogenic phenotypes. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25959774",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Disruption of TAD boundaries results in aberrant gene expression by exposing genes to inappropriate regulatory elements. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27111891",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Disruption of TADs can result in altered gene expression and is associated to genetic diseases and cancers. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30086749",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Disruption of a TAD boundary causes ectopic chromosomal contacts and long-range transcriptional misregulation. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22495304",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Recent studies of TAD boundaries disrupted in engineered mouse models show that boundary mutations can recapitulate human developmental disorders as a result of aberrant promoter-enhancer interactions in the affected TADs. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28408976",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Recent studies have shown that TAD disruption is often found in cancer cells and contributes to oncogenesis through two mechanisms. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27111891",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Disruption of this organization by structural variations can lead to ectopic interactions between enhancers and promoters, and to alteration of genes expression patterns. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30374058",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Similar boundary disruptions in certain cancers can result in oncogene overexpression, and CTCF binding sites at boundaries appear to be hyper-mutated across cancers. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28408976",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "However, it is not clear to which extent TAD regions are conserved in evolution and whether disruption of TADs by evolutionary rearrangements can alter gene expression. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30086749",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}